Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma

Yang, Y; Feng, TT; Fan, XJ; Wang, CC; Jiang, YH; Zhou, X; Bao, W; Zhang, DH; Wang, S; Yu, JP; Tao, YL; Song, G; Bao, H; Yan, JR; Wu, X; Shao, Y; Qiu, GQ; Su, D; Chen, QX

Qiu, GQ (通讯作者),Chinese Acad Sci, Zhejiang Canc Hosp, Hangzhou Inst Med HIM, Dept Thorac Radiotherapy, Hangzhou, Zhejiang, Peoples R China.;Qiu, GQ (通讯作者),Zhejiang Key Lab Radiat Oncol, Hangzhou, Peoples R China.;Su, D (通讯作者),Chinese Acad Sci, Zhejiang Canc Hosp, Hangzhou Inst Med HIM, Dept Pathol, Hangzhou, Zhejiang, Peoples R China.;Chen, QX (通讯作者),Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc IBMC, Dept Urol Surg, Hangzhou, Zhejiang, Peoples R China.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023; 117 (4): 979

Abstract

Purpose: The effect of genomic factors on the response of patients with esophageal squamous cell carcinoma (ESCC) to neoadjuvant chemoradiotherapy (nC......

Full Text Link